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Abstract
Severe durable changes may occur to the DNA structure caused by exogenous and endogenous risk factors initiating the process
of carcinogenesis. By evidence, a large portion of malignancies have been demonstrated as being preventable. Moreover, the
targeted prevention of cancer onset is possible, due to unique properties of plant bioactive compounds. Although genoprotective
effects of phytochemicals have been well documented, there is an evident lack of articles which would systematically present the
spectrum of anticancer effects by phytochemicals, plant extracts, and plant-derived diet applicable to stratified patient groups at
the level of targeted primary (cancer development) and secondary (cancer progression and metastatic disease) prevention.
Consequently, clinical implementation of knowledge accumulated in the area is still highly restricted. To stimulate coherent
co-development of the dedicated plant bioactive compound investigation on one hand and comprehensive cancer preventive
strategies on the other hand, the current paper highlights and deeply analyses relevant evidence available in the area. Key
molecular mechanisms are presented to detail genoprotective and anticancer activities of plants and phytochemicals. Clinical
implementation is discussed. Based on the presented evidence, advanced chemopreventive strategies in the context of 3P
medicine are considered.
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Introduction
The traditional use of medicinal plants led to the discovery of
numerous bioactive compounds representing potent tools in
the therapy approaches and disease prevention [1]. Major ben-
efits of isolated chemical compounds or their mixtures found
in fruits, vegetables, beans, and other plant sources include
anti-inflammatory, antioxidant, antibacterial, antifungal, and
other health beneficiary effects [2–6].
Recently, plant natural substances are at the center of
scientific interest due to their anticancer activity as de-
scribed elsewhere [2, 7, 8]. For instance, an evidence sug-
gests a correlation between higher consumption of
phytochemical-rich foods and lower risk of cancer develop-
ment [9–11]. Additionally, the antineoplastic efficacy of
phytochemicals can be mediated via the maintenance of
genome stability. Genotoxicity can be interpreted as harm-
ful genetic changes such as gene mutations, recombination,
or chromosomal aberrations in the presence of genotoxins
action [12]. Multiple genomic events as a consequence of
carcinogen exposures or disbalance of anti and prooxidative
reactions characterize tumour evolution [13]. Healthy cells
have evolved mechanisms to inactivate free radicals or car-
cinogenic chemicals and thus prevent DNA damage [14].
On the other hand, the imbalance and/or deficits within
DNA-repair cascades can be associated with initiation, pro-
motion, and progression of carcinogenesis [15]. Therefore,
the human environment and dietary habits play a crucial role
in cancer etiology [16].
Despite the use of various anticancer drugs which im-
prove symptoms and increase patient survival, many can-
cers remain incurable, mainly due to advanced cancer
stages diagnosed, deficient patient stratification, and
neglected individualised patient profiles [17]. As such, in-
troducing new clinical approaches reducing cancer risks
would be highly beneficial for healthcare as a whole. To
this end, instability of DNA structure as critical aspect of
carc inogenes is under cer ta in condi t ions can be
chemoprevented by plant-derived bioactive compounds
(phytochemicals) resulting in reduced risks of cancer de-
velopment [18–26]. This review highlights central mecha-
nisms of phytochemicals as natural genoprotectors, pre-
sents a spectrum of their anticancer properties, and con-
siders their potential application for individuals at risk
and patients in the context of 3P medicine, namely, predic-
tive diagnostics, targeted primary and secondary preven-
tion, and personalisation of treatments.
Sources of data used
English-language biomedical literature sources from PubMed
database were analysed for the topic-related items including
all the keywords listed above. The most recent scientific pub-
lications originated from years 2015–2020 were particularly
taken into consideration for the final statement presented in
the paper.
DNA damaging agents
Carcinogenesis is associated with extensive DNA damage,
which is often caused by an exposure to various exogenous
and endogenous agents. Thus, maintaining genomic integrity
is crucial for the well-being of the organism [27]. Medication
applying DNA damaging agents against cancer utilizes the
biologic difference in the response between normal and tu-
mour cells towards DNA injury, due to highly increased pro-
liferation of the latter [28]. Figure 1 highlights exogenous and
endogenous agents causing DNA damage.
Oxidative stress and reactive oxygen species (ROS)
Oxidative stress is caused by an imbalance between ROS
formation and scavenging. Increased production of ROS
has been detected in various cancer types with important
roles in the activation of pro-tumourigenic signalling, en-
hancement of cell survival, and proliferation or drive of
DNA damage and genetic instability [29]. Modifications
of nitrogen bases in DNA or its sugar-phosphate backbone
can be caused by ROS, which disrupt gene function and
impair transcription, DNA replication, and cell prolifera-
tion [30]. Hydrogen peroxide (H2O2) is a relatively weakly
reactive ROS and acts as a mild oxidising/reducing agent.
H2O2 can oxidize DNA, lipids, and proteins mainly in in-
creased presence of hyperreactive thiol groups or methio-
nine residues [31]. In addition, DNA damage can be caused
by inducers of ROS such as tert-butyl hydroperoxide (t-
BOOH) [32]. The level of DNA damage arising from oxi-
dative stress can be measured by analysis of level of 8-
hydroxy-2′-deoxyguanosine (8-OHdG) or 8-oxo-7,8-
dihydro-2′-deoxyguanosine (8-oxodG), which are widely
used biomarkers for oxidative stress and carcinogenesis
[33].
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Cyclobutane pyrimidine dimers
An accumulation of UV-specific mutations caused by direct
absorption of UV photons, such as pyrimidine dimers, is
closely associated with melanoma skin cancer. UVA-
induced cyclobutane pyrimidine dimers (CPDs) are formed
between adjacent thymine bases, by either direct excitation
or photosensitisation leading to disruption of the normal cel-
lular processing of DNA. This DNA damage causes various
biological responses including apoptosis, immune suppres-
sion, and carcinogenesis [34, 35].
Exposure to carcinogens
Exposure to carcinogens is associated with occurrence of
electrophiles or ROS and can result in the cancer initiation
and promotion. Carcinogens cause damage of DNA includ-
ing single-strand breaks (SSBs) or double-strand breaks
(DSBs), oxidative-induced lesions, covalently bound
DNA chemical adducts, and DNA-DNA or DNA-protein
cross-l inks [36]. Carcinogens are represented by
heterocyclic aromatic amines (tobacco smoke, diesel ex-
haust, incineration ash), polycyclic aromatic hydrocarbons
(roasting, grilling, baking, smoking), ultraviolet (UV) and
infrared (IR) radiation, aristocholic acid, nitrosamines
(drugs, cosmetics, rubber industry), mycotoxins, asbestos,
and some nanoparticles [36, 37]. Specific examples of car-
cinogens and their DNA damaging mechanisms are
summarised in Table 1.
Molecular mechanisms involved
in genoprotective action
Damage of DNA is essential for the induction of mutations
associated with initiation, promotion, and progression of car-
cinogenesis [15]. Accordingly, healthy cells must be defended
against DNA damage caused by endogenous and exogenous
agents and decrease the mutagenic processes. As discussed
below, molecular mechanisms of genoprotective agents are
involved in the protection against DNA damage.
Fig. 1 Endogenous and




carcinogens exposure act as the
main initiators of DNA damage.
ROS, reactive oxygen species;
H2O2, hydrogen peroxide; CPDs,
cyclobutane pyrimidine dimers;














B1; IR, ionising radiation; UVA,




EPMA Journal (2020) 11:261–287 263
Antioxidant activity
ROS directly oxidize DNA and interfere with various mecha-
nisms of DNA repair, triggering DNA chain breaks, base
modification, and other oxidative DNA lesions [56]. In cancer
management, ROS scavenging is an important antioxidant
mechanism with an effort to reduce tumour growth and sur-
vival of cancer cells and can be achieved by different types of
plant-derived phytochemicals [57–59]. ROS can be scav-
enged via either enzymatic or non-enzymatic pathways such
as glutathione (GSH), thioredoxin (Trx), superoxide dismut-
ase (SOD), catalase (CAT), and peroxidases [60, 61].
Cellular defense against oxidative stress is mediated
mainly by an activation of the Nrf2-antioxidant response
element signalling pathway. Under physiological condi-
tions, the Nrf2 expression is regulated through the binding
to Keap1 which is associated with Nrf2 degradation [62].
On the contrary, upon oxidative stress, this binding is
interrupted and Nrf2 can translocate to the nucleus and bind
an antioxidant response element (ARE) sequences that are
present in enhancer regions of cytoprotective genes.
Subsequently, these genes encode enzymes and proteins
with the function in the balance of redox homeostasis and
detoxification oxidants or electrophiles. Furthermore,
cytoprotective genes code an ability to remove or repair
damaged DNA and proteins [63–65].
Nrf2-independent pathway is involved in the protection
against ROS-induced DNA damage. Aryl hydrocarbon recep-
tor (AhR) is defined as ligand-activated transcription factor,
which binds to exogenous ligands leading to nuclear translo-
cation of AhR and consequent dimerisation with associated
AhR protein. A subsequent interaction between the heterodi-
mer with consensus DNA sequence xenobiotic responsive
element and the enhancer regions of target genes increases
their transcription [37, 66]. Inactivation of carcinogens, such
as B[a]P by phytochemicals, can lead to the protection against
DNA damage as was demonstrated in several studies
concerning cancer chemoprevention and therapy [67–69].
Table 1 Specific groups of
carcinogens and their DNA
damaging mechanisms
Groups Carcinogens Mechanisms of DNA damage References
Radiation UVA Direct formation of DNA lesions, oxidation, and
damage to DNA repair proteins
[38]
UVB ↑ CPDs [39]
IR ↑ DSBs, secondary effects: generation of abasic sites
and SSBs
[40]
PAH B[a]P ↑ B[a]P diol epoxidation (BPDE) and BPDE–DNA
adducts
[41]
DMBA ↑ Covalent adducts with DNA, formation of
depurinated abasic sites within DNA
[42]
HAA PhIP ↑ DNA adducts: PhIP-C8-dG [37]
IQ ↑ IQ-DNA adducts [43, 44]
N-nitroso-compounds NDMA ↑ DNA adducts, the conversion into methylamines and
induction of o-methylguanine
[45]
Drugs DXR ↑DNADSBs and DNA adducts, ↑ oxygen free radicals [46]
MMC Alkylation DNA, generation DNA cross-links [47]
DES ↑ DES-DNA adducts (3′-OH-DES-6′-N3Ade and
3′-OH-DES-6′-N7Gua)
[48]
ETP Topoisomerase II inhibitor, ↑ DNA DSBs [49]
Alkylating agents MNU/NMU ↑ DNA methylation adducts O(6)-methylguanine,
minor products: O2-methylcytosine (O2MeC) and
O2-methylthymine (O2MeT)
[50, 51]
AOM Mutation in exon 3of Ctnnb gene, constitutive
activation of the Wnt pathway
[52]
Mycotoxins AFB1 ↑ AFB1-DNA adducts (AFB1-N(7)-guanine) [53, 54]
Environmental Arsenic DNA repair inhibition, gene expression alterations via
epigenetic modifications
[55]
PAH polycyclic aromatic hydrocarbon;HAA heterocyclic aromatic amines;UVA ultraviolet A;UVB ultraviolet B;
IR ionising radiation; B[a]P benzo[a]pyrene; DMBA 7,12-dimethylbenz[a]anthracene; PhIP 2-amino-1-methyl-
6-phenylimidazo[4,5-b]pyridine; IQ 2-amino-3-methylimidazo[4,5-f]quinoline;NDMAN-nitrosodimethylamine;
DXR doxorubicin; MMC mitomycin C; DES diethylstilbestrol; ETP etoposide; MNU/NMU N-methyl-N-
nitrosourea; AOM azoxymethane; AFB1 aflatoxin B1; CPDs cyclobutane pyrimidine dimers; DSBs double-
strand breaks; SSBs single-strand breaks
↑increase/induce
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Under specific cellular conditions, antioxidants can also act
as prooxidants, which promote production of ROS, subse-
quently cause different DNA damage and initiate mutagene-
sis. To determine the prooxidant status, the concentration of
several reductant-oxidant markers, including glutathione
(GSH) to GSSG, NADPH to NAPD−, and NADH to NAD−,
has to be evaluated [70]. The prooxidant activity is
catalysed by metals, especially transition metals present in
biological systems such as iron (Fe) and copper (Cu) [71].
The prooxidant effect was observed in numerous phenolic
compounds including flavonoids [72, 73]. Moreover, cytotox-
ic level of ROS caused by prooxidant compounds is increased
in cancer cells probably due to the higher concentration of
iron/copper ions and greater metabolic activity compared with
normal cells [74]. Inhibition of prooxidative enzyme activa-
tion, including the GSH, thioredoxin (TXN), or NADPH ox-
idase, can represent a potential target in cancer prevention and
treatment [75, 76].
Detoxification processes
In mammals, metabolic activation of phase I and phase II
enzymes is involved in liver detoxification of various classes
of environmental carcinogens. These enzymes can enhance
the elimination of carcinogens and protect DNA against dam-
age [77, 78]. Cytochrome P450 (CYP) is the main enzyme of
phase I detoxification, which converts xenobiotics to active
intermediates [79]. In tumour tissues, CYP cause resistance by
metabolising and, therefore, targetly deactivating the cyto-
statics [80]. Phase II detoxification enzymes, including gluta-
thione S-transferases (GSTs), NAD(P)H:quinone oxidoreduc-
tase 1 (NQO1), and heme oxygenase-1 (HO-1), catalyze the
conjugation of these active intermediates by sulfation or
glucuronidation [81]. Moreover, GST activity can apparently
influence DNA stability and repair process towards
oxidised bases [82].
Cellular mechanisms of antioxidant defense system and
detoxification are included in Fig. 2.
DNA repair mechanisms
In case of a mild damage of DNA (the repair of DNA is
possible), various signalling cascades are activated by cells
to restore the original genetic information. Genetic mutations
in genes coding the DNA repair may contribute to the cancer
initiation. DNA damages, such as DSBs and SSBs, activate
pair of related protein kinases ATM and ATR, respectively. In
case of mutations, ATM and ATR phosphorylate several com-
mon substrates leading to an initiation of a cascade resulting in
cell cycle arrest and DNA repair [83].
The simplest process to repair SSBs induced by ROS is
base excision repair (BER). DNA repair of base damage via
BER is provided by four enzymes including a DNA
glycosylase, AP-endonuclease I (APE1), DNA polymerase
β (Polβ), and a DNA ligase [84, 85]. OGG1 is a repair en-
zyme 8-oxoGua DNA glycosylase 1 that removes the
oxidised purine from DNA as the first step in BER. AP endo-
nuclease bypasses the AP lyase activity of OGG1, thus en-
hancing OGG1 turnover (APE1) [18]. Moreover, other repair
mechanisms, such as two types of nucleotide excision repair
(NER) and DNA mismatch repair (MMR), are closely linked
to cancer cells. In transcription-coupled nucleotide excision
repair (TC-NER), DNA damage is recognised by XPC en-
zyme and the double strand of DNA is subsequently unfolding
from both sides through the presence of helicases XPA, XPG,
and TFIIH. Damaged DNA is removed and the synthesis of a
new strand can start [86]. Furthermore, other global genomic
nucleotide excision repair (GG-NER) mechanisms may repair
damage in transcribed or untranscribed DNA strands through-
out the genome [87]. Small loops in DNA can be
recognised and repaired by MMR either by base-base mis-
matches or by insertion/deletion loops [88]. NER and BER
systems repair damages affecting just SSBs and the lesions
involving exogenous and endogenous sources, respectively
[89].
More problematic DSBs are primarily repaired by error-
free pathway called homologous recombination (HR) operat-
ing in the S and G2 phases of the cell cycle and non-
homologous end joining (NHEJ), which tends to be error
prone and acting in all phases of the cell cycle [90].
Responsibility for genome instability of cells is due to the
disruption of many alternative but highly error prone DNA
DSB repairs such as single-strand annealing (SSA),
microhomology-mediated end joining (MMEJ), and NHEJ
[91, 92]. SSA pathway is a mutagenic DSB repair pathway
in comparison with error-free HR during S/G2 phases [93].
These error prone DSB repair mechanisms can lead to carci-
nogenesis [94, 95]. Activation of error prone DNA-repair sig-
nalling pathways is involved in the resistance of tumour cells
to therapies. An inhibition of these repair mechanisms shows a
potential in anticancer treatment [89]. Figure 3 overviews the
repair mechanisms, which are involved in the protection
against various DNA damage.
Genoprotective activities of plant natural
compounds evaluated in preclinical research
Phytochemicals, either as single substances or their mixtures
present in plants, have recently been a highly topical issue of
cancer research. Additionally to the significant anticancer
properties of plant compounds in already initiated process of
carcinogenesis in vitro, in vivo, or in clinical sphere [96–100],
their widespread use in cancer chemoprevention should not be
forgotten. Plant natural compounds exhibit significant
genoprotective effects such as protection against DNA
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damage, detoxification of carcinogens, or induction of DNA
repair [101, 102].
Antioxidant activity of plant natural substances
Non-cancer models
The protective efficacy of whole natural substances against
DNA damage was evaluated in several preclinical studies.
As examples , we can desc r ibe a t ropica l p lan t
Chrysobalanus icaco L. (CHI) exerted antigenotoxicity in pe-
ripheral blood cells, antimutagenicity in bone marrow cells
and peripheral blood cells, and decreased oxidative stress in
peripheral blood neutrophils in Wistar male rats after doxoru-
bicin (DXR)-induced DNA damage and generation of ROS.
Chemopreventive efficacy of CHI was noted as an inhibition
of NADPH oxidase complex with low levels of DNA damage
in rats after DXR exposure. Antunes with co-authors (2016)
stated that the genoprotective effect against DXR-induced
DNA-damage in vivo was attributed to the phytochemicals
and minerals present in CHI exhibiting strong antioxidant
properties [103]. Lemongrass essential oil (LEO) that consists
mainly of citral (68.78%) demonstrated several pharmacolog-
ical, mostly anti-oxidant, and cancer preventive activities.
LEO protected human embryonic lung fibroblasts (HELFs)
against B[a]P-induced loss of cell viability. Moreover, un-
treated HELFs exposed to B[a]P showed an increased activity
of malondialdehyde (MDA) and a reduced activity of CAT
and SOD. Importantly, opposite effect in enzyme activities
was observed in HELFs treated with LEO. Additionally, an
efficacy of LEO to decrease DNA damage was proven by
reduction of 8-OHdG level, indicating LEO as a promising
agent in lung cancer chemoprevention [104].
Additionally, Allium cepa L. and A. × cornutumClementi ex
Visiani are common onions which contain large amount of
flavonoid quercetin that shows a specific role in different bio-
logical processes including cancer [105, 106]. Studies of the
DNA protection revealed that the presence of both methanolic
extracts of A. cepa L. and A. cornutum reduced DNA damage,
especially DNA strand breaks in human leukocytes.
Antioxidant activity was observed in both extracts but slightly
higher for Allium cornutum due to the higher phenolic content.
In DNA nicking assay generated by Fenton reaction, higher

























































Fig. 2 Antioxidant and detoxifying processes involved in genoprotective
activities. Part A demonstrates the metabolic processes of phase I
(Cytochrome P450) and phase II (GSTs, NQO1, HO-1) enzymes in-
volved in detoxification of environmental carcinogens. Part B describes
the ROS scavenging activity via either enzymatic or non-enzymatic path-
ways, Nrf2-antioxidant response element signalling pathway, and AhR-
dependent pathway. SOD1, superoxide dismutase 1; SOD2, superoxide
dismutase 2; SOD3, superoxide dismutase 3; H2O2, hydrogen peroxide;
GSH, glutathione; GR, glutathione reductase; GSSG, glutathione disul-
fide; NADP, nicotinamide adenine dinucleotide phosphate; XO, xanthine
oxidase; AhR, aryl hydrocarbon receptor; Nrf2, nuclear factor erythroid
2-related factor 2; KEAP1, Kelch-like ECH-associated protein 1; TRX,
thioredoxin; GRX, glutaredoxins; ARE, antioxidant response element;
XRE, xenobiotic response element
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activity of free radicals and the ability to maintain DNA in
supercoiled structure. Due to high level of quercetin, Allium
cornutum and A. cepa proved to catch and inactivate hydroxyl
radicals in H2O2-induced DNA damage in human leukocytes.
On the contrary, higher dose of Allium cornutum and A. cepa
can also provoke oxidative DNA damage mainly by structural
characteristics of phenolic compounds which can concurrently
play a role as antioxidants and prooxidants. Authors concluded
a protective role of A. cepa and A. cornutum on DNA strand
breaks via the antioxidant activity [106]. Furthermore,
Euphorbia dracunculoides methanol extract (EDME) revealed
hepatoprotective and genoprotective effects against oxidative
stress and genotoxicity induced with CCl4 in the liver of
Sprague-Dawley male rats. Administration of EDME in diet
of rats increased the levels of antioxidant enzymes (CAT, per-
oxidase (POD), and SOD), and phase II enzymes (GST and
GSH) in liver tissues after CCl4 injection compared with con-
trol. Similarly, EDME decreased the level of lipid peroxides
such as thiobarbituric acid reactant substances (TBARS), ni-
trite, and hydrogen peroxide in liver tissue. Moreover, decline
in the level of DNA damage, including DNA strand breaks
caused by CCl4, was observed in hepatocytes of EDME-
treated rat group compared with control [107].
Cancer models
Brachystegia eurycoma (BE) from South Eastern Nigeria also
known as “Achi” prevented N-methyl-N-nitrosourea (MNU)-
induced increasement of MDA and carcinoembryonic antigen
(CEA). Chemopreventive study on male Wistar rats demon-
strated the hard-mucosal ulceration in the colon associated
with inter-glandular inflammation in control group with a sin-
gle treatment of MNU. On the other hand, only moderate or
even no inflammation in the colon in the MNU groups
pretreated with BE was detected. Furthermore, studies on the
colon revealed that the BE pretreatment to great extent
prevented MNU-induced DNA damage to mismatch repair
gene MutL homolog1 (MLH1) [108], which mutations are
considered biomarkers of carcinogenesis [23]. Furthermore,
histological analysis showed oxidative damage in the MNU
control group, but not in BE pretreated groups. Moreover, a
good correlation was detected between the MLH1 expression
Fig. 3 Repair mechanisms involved in genoprotective activities.
Mutation causes the phosporylation of substrates by ATM and ATR
recognising DSBs and SSBs, respectively. SSBs are associated with
three different repair mechanisms including NER (TC-NER and GG-
NER), BER, and MMR. DSBs can be repaired primarily via error-free
HR but in case of defect of HR, error-prone SSA, NHEJ, or MMEJ are
involved in repair. ssDNA, single-strand DNA; dsDNA, double-strand
DNA; ROS, reactive oxygen species; HR, homologous recombination;
SSA, single-strand annealing; MMEJ, microhomology-mediated end
joining; NHEJ, non-homologous end joining; MMR, DNA mismatch
repair; BER, base excision repair; NER, nucleotide excision repair;
ATM, protein kinase ataxia-telangiectasia mutated; ATR, ataxia telangi-
ectasia and Rad3-related protein; OGG1, 8-oxoguanine glycosylase;
APE1, human apurinic/apyrimidinic endonuclease 1 Polβ, polymerase
β; GG-NER, global genomic nucleotide excision repair; TC-NER,
transcription-coupled nucleotide excision repair; XPC, CSA, Cockayne
syndrome group A protein; CSB, Cockayne syndrome group B protein;
RNAPII, RNA polymerase II; XPA, DNA repair protein complementing
xeroderma pigmentosum-A cells; XPG, DNA repair protein
complementing xeroderma pigmentosum-G cells; TFIIH, transcription
factor II H
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and the CEA (r = 0.361, p < 0.05). Results suggested strong
genoprotective activity in the colon via the high antioxidant
potential of BE intake [108].
Another study, focused on bioactive compounds of Butea
monosperma (Lam.) which contains chalcones butein, and
isobutrin, and flavonoid butrin, demonstrated anticancer ac-
tivities [109, 110]. An antioxidant activity of different extracts
ofB. monospermawasmeasured byDPPH assay. Chloroform
and ethyl acetate extracts exhibited pronounced antioxidant
activity. Both extracts were shown to protect plasmid DNA
of E. coli plasmid pBR322 against hydroxyl radical induced
DNA damage. Extracts also exerted antiproliferative proper-
ties and apoptotic activity through the cell cycle arrest in G1
and sub-G1 phase, enhanced ROS levels, and induced DNA
DSBs in MCF-7 breast carcinoma cells [111]. Furthermore,
extracts from wines and grapes are rich in polyphenols which
can modulate colonocyte mutagenesis and subsequently pre-
vent tumour initiation and promotion [9]. A powdered red
wine pomace seasonings (RWPSs) (Sk-S: seedless, W-S:
whole, Sd-S: seeds) demonstrated the genoprotective effects
against oxidative DNA damage in HT-29 cells [112]. An abil-
ity to prevent DNA against oxidative damage via RWPSs was
enhanced progressively along digestion resulting in differ-
ences from undigested (UD) to colonic fermented (CF) frac-
tions forW-S and between all fractions for Sd-S. In addition to
genoprotective effects, the study also determined the
antigenotoxic and antiproliferative efficacy of RWPSs in
HT-29 colon cancer cells with potential in cancer chemopre-
vention [112].
Glucosinolates, abundantly presented in Brassica vegeta-
bles, are hydrolysed during digestion to different products in-
cluding indole-3-carbinol (I3C). Under acidic condition. I3C
polymerizes to indolo[3,2-b]-carbazole (ICZ) [113] with po-
tential anticancer efficacy. An influence of ICZ in the protec-
tion against oxidative DNA damage was evaluated in Caco-2
colon carcinoma cell line. The level of DNA strand breaks after
pretreatment with ICZ and subsequent exposition to
genotoxins t-BOOH, H2O2 or B[a]P that produce oxidative
stress was diminished in Caco-2 cells. On the other hand, si-
multaneous addition of ICZ did not protect against t-BOOH-
induced strand break formation leading to disproof of the direct
radical scavenging effect. Interestingly, ICZ did not play a role
in SSB repair through the BER, which was not associated with
altered expression of BER proteins such as OGG1, APE,
PARP1, and XRCC1 in Caco-2 cells. Moreover, ICZ activated
ROS scavenging effect with proven low level of 8-OHdG in
pretreated Caco-2 cells; however, the antioxidant response
pathway of ICZ was independent of Nrf2. It was demonstrated
that ICZ activated AhR being protective against oxidative
DNA damage in Caco-2 cells. The results suggest that the
AhR-dependent pathway was associated with protective activ-
ity against ROS-induced DNA damage in colorectal carcino-
genesis, and was independent of the Nrf2 pathway [20].
MDA is often used as a marker of the oxidative damage of
lipids by free radicals. Recently, we have found that dietary
administered clove buds, thyme, and cinnamon, rich in anti-
oxidants, decreased the MDA level in mammary cancer cells
in vivo [2, 7, 114–116]. Moreover, young barley leaves and
fruit peels polyphenols also lowered the levels of dityrosines,
the product of oxidative stress, in mammary cancer cells
in vivo [114]. Our results indicated significant antioxidant
effects of these plant natural substances in rat carcinoma
models and indicated potential genoprotective mechanisms
and chemopreventive activity in mammary carcinogenesis.
Detoxification processes via plant natural substances
Non-cancer models
Administrating Crataegus songarica methanol extract
(CSME) to rats demonstrated antitumour activity, protection
against DNA damage, and protection of the kidney and heart
tissue against CCl4-induced toxicity. CSME decreased serum
creatinine, urea, cholesterol, and MDA level in the kidney and
heart tissue. The suppression of GSH, GR, GPx, and GST
enzyme activity was also detected in both the kidney and heart
tissue. In addition, CSME showed protective effect against
CCl4-induced DNA damage of kidney and heart tissue [117].
Cancer models
Sage tea (Salvia officinalis, SO) demonstrated a chemopre-
ventive effect against azoxymethane (AOM)-induced
preneoplastic lesions of colon cancer in vivo. Comet assay
revealed that SO treatment protected DNA against AOM-
induced or H2O2-induced damage in colonocytes isolated
from female rats. Moreover, SO decreased the proliferation
marker Ki67 in the colon. Interestingly, effects of SO in the
inhibition of cancer initiation were not proven by increased
excretion through GST induction or decreased bioactivation
by cytochrome P450 2E1 (CYP2E1) in liver homogenates.
Results indicated that the consumption of SO tea may prevent
the development of colon cancer via various mechanisms such
as protection against DNA damage and modulation of cell
proliferation resulting in prevention of mutations and their
fixation through the cell replication [118]. Thymus revolutus
Célak essential oil (TRCEO) and its two main constituents, γ-
terpinene and p-cymene, have been demonstrated as potential
as oxidative agents in lung cancer cells (H1299 and A549) and
epidermoid carcinoma cells (A431). Activity of antioxidant
enzymes in cancer cells was depended on concentration of
TRCEO components and prooxidant/antioxidant effects of
extract. IC50 and IC70 concentrations of TRCEO, γ-terpinene,
and p-cymene caused oxidative stress. Parental H1299 cells
were the most sensitive to the cytotoxic effects of all tested
compounds. The highest membrane and DNA damages were
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observed in A431 and A549 cells, respectively. TRCEO, γ-
terpinene, and p-cymene increased the MDA levels and 8-
OHdG formation in all cancer cells used. Additionally, they
increased glutathione reductase (GRx), glutathione peroxidase
(GPx), GST, and glucose 6-phosphate dehydrogenase
(G6PD) activity. These compounds demonstrated antitumour
and prooxidative effects with subsequent induction of cyto-
toxic death of cancer cells [119]. Flaxseed consumption re-
duced oxidative stress and inflammation in tobacco smoke
carcinogen (NNK)-induced lung tumourigenesis in A/J mice.
Noteworthy, 10 % flaxseed in the diet altered expression of
several CYPs, GSTs, and UDP-glucuronosyltransferase
(UGTs). Flaxseed also reduced expression of pro-
inflammatory cytokines (IL-1α, IL-6, IL-8, and IL-9) and in-
creased the expression of anti-inflammatory cytokine
(IL-12α) in lung tissues suggesting chemopreventive proper-
ties of flaxseed elicits and associated detoxification of NNK
[120].
Methanol extract ofPongamia pinnata seeds (MEPPS) and
its secondary metabolites pongapin and lanceolatin B showed
chemopreventive potential due to their ability to inhibit
CYP1A1 and protect CYP1A1-overexpressing HEK293 hu-
man embryonic kidney cells against B[a]P-induced toxicity.
Additionally, MEPPS and its metabolites also induced the G0-
G1 phase cell cycle arrest of CYP1A1-overexpressing MCF-7
breast cancer cells, and suppressed cyclin D1 levels leading to
cellular senescence [121].
DNA repair mechanisms via plant natural substances
Non-cancer models
Several studies were focused on genoprotective activities
associated with various plant extracts. Extract of Sechium
edule (SEE) fruit from Cucurbitaceae family is rich in
amino acids, saponins, sugars, and flavonoids [122].
Genoprotective activities of SEE against UVA-induced
DNA damage in normal human keratinocytes (NHK) were
evaluated. SEE increased DNA repair capacities, the
maintenance of proliferation, and preservation of stemness
property of NHK after UVA exposure. Furthermore, SEE
reduced UVA-induced oxidative DNA damage by 30 %
compared with control. Oxidised DNA bases modified by
ROS in NHK with SEE treatment were repaired via the
BER pathway. The upregulation of BER genes OGG1 and
MYH in mRNA levels was detected; however, the expres-
sion levels of APE1, POL β, LIG3, UNG, and XRCC
remained unchanged. Noteworthy, global DNA repair
pathways were influenced not only through BER but also
through the NER pathway with positive impact on the
repair of small oxidative DNA lesion and photoproducts
in NHK. Moreover, an amount of CPD, predominant
DNA lesions after UVA irradiation in human skin [123],
was undoubtedly increased in untreated NHK. On the
contrary, number of CPD after UVA exposure was re-
duced in NHK treated with SEE suggesting the stimula-
tion of repair of such photoproducts [124]. Ficus carica
leaf extract (FCE), which is native to Egypt or Western
Asia, reduced DNA damage and reversed non-steroidal
estrogen (DES)-induced DNA damage, especially strand
breaks in non-tumourigenic MCF10A human breast epi-
thelial cell line. FCE stimulated DNA repair and
optimised comet formation resulting from the irreversible
interaction of oxidative quinine metabolites of DES
(DESQ) with the nuclear apparatus causing DNA damage
[125], keeping in mind DES binds to both estrogen recep-
tors ER-ɑ and ER-β [126]. Overall, the study demonstrat-
ed both a chemopreventive and cancer therapeutic role of
FCE in early-stage breast cancer [125].
Cancer models
Hemidesmus indicus (L.), also known as Indian sarsaparilla, is
an Indian weed with healing effects of the crude root in
Ayurvedic medicine [127]. Study evaluating the cancer che-
mopreventive and therapeutic potential demonstrated the
genoprotective effects of H. indicus hydro-alcoholic extract
(HIHE) in pre-, co-, and post-treatment in DLD1 colorectal
adenocarcinoma cells and in CCRC-CEM T-lymphoblastic
cells. Genoprotective properties were evaluated after exposure
to genotoxic agents such as etoposide, DXR, and H2O2. HIHE
soxhlet strongly reduced the genotoxicity of etoposide associ-
ated with a reduction up to 47.3 %, 42.6 %, and 29.2 % in the
H2AX phosphorylation in the pre-, co-, and post-treatment,
respectively. Similar effect was observed after treatment with
DXR and H2O2. HIHE pre-treatment played a critical role in
genoprotective activity against DNA damage. Additionally,
HIHE significantly decreased the cell viability and cell prolif-
eration demonstrated via reduced Ki67 levels in DLD1 and
CCRC-CEM cells. Moreover, the cell cycle arrest in S phase
for low concentration and G2/M arrest for higher concentra-
tion was observed after 24-h HIHE treatment in CCRC-CEM
cells. Results suggested that several mechanisms can be in-
volved in genoprotective activity of HIHE by reducing the
rates of absorption and uptake of the genotoxic agent and by
modulation of DNA repair, cell cycle, or apoptosis at extra-
and intracellular level [128].
Isolated phytochemicals from plants also demonstrated
genoprotective action in cancer chemoprevention and treat-
ment. FANCA proteins are key players in the canonical
Fanconi anemia (FA) repair pathway with impaired response
to DNA damage through the HR. Predisposition to breast
cancer, including mutation in BRCA1 and BRCA2 (one of
the FA protein) gene, is mainly due to disruption of many
DNA DSB repairs. High FANCA expression supports the
survival of cancer cells despite the DNA damage with
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subsequent genomic instability via SSA repair. Withaferin A
(WA) is a steroidal lactone isolated from winter cherry
(Withania somnifera (L.) Dunal) that has an ability to reduce
FANCA protein levels and downregulates HSP90 expression
in MDA-MB-231, SUM-149, MCF-7 breast cancer cells, and
U2OS osteosarcoma cells as a platform of DSB repair reporter
assays which demonstrated the disrupted interaction between
FANCA-HSP90. Additionally, these processes were associat-
ed with a defect in WA-induced SSA repair, abolition of
FANCD2 monoubiquitination, increased sensitivity to mito-
mycin C leading to accumulation of DSBs. Despite that
FANCA and RAD52 are the major catalytic factors in the
SSA subpathway of DNA DSB repair, WA reduced only
FANCA but not RAD52 level. In conclusion, defect in SSA
repair induced by WA is dependent on the FANCA protein
absence. Moreover, overexpression of exogenous WT-
FANCA protein complements the repair defect in WA-
treated cells [21].
Taken together, the above studies demonstrate that plant
natural substances exert potential genoprotective activities
in vitro and in vivo, which suggest their application in chemo-
prevention of various cancer types (Table 2).
Plant bioactive compounds formulated as
nanoparticles
Nanotechnologies represent modern multidisciplinary and in-
terdisciplinary approach connected with many applications in
scientific research [129, 130]. As detailed above, phytochem-
icals have a promising potential for human health in
preventing or treating various civilisation diseases, including
malignant transformation [99, 131, 132]. However, few unde-
sirable aspects, such as their low solubility in water, low sta-
bility, or some side effects, are associated with higher doses of
plant bioactive compounds and limit their application
[133–135]. However, nanoparticles are able to eradicate these
processes [129], which are important in the maintenance of
genomic stability. Consequently, some studies predicted that
green synthesis of nanoparticles is an innovative and future
treatment strategy against tumour initiation, promotion, or
progression [136–139].
Recently, an antigenotoxic effect of biosynthesised silver
nanoparticles (SNPs) of Ocimum sanctum leaf extract
against cyclophosphamides (oxazaphosphorines acting
a s t h e a l k y l a t i n g a g e n t s ) h a s b e e n a n a l y s e d .
Biosynthesised nanoparticles of O. sanctum exerted a pro-
tective effect on the human lymphocytes after cyclophos-
phamide intervention. SNPs at concentrations of 50, 100,
and 200 μl/ml demonstrated a significant decrease in chro-
mosomal damages comparedwith controls.Higher level of a
mitotic index of treated lymphocytes was also observed as a
consequence of the protection role green SNPs in genome
stabil i ty [25] . Genoprotect ive abi l i t ies of green-
synthesised selenium nanoparticles of Terminalia arjuna
leaf extract against arsenic-induced genotoxicity and cell
death were analysed in human lymphocytes. Acquired data
revealed a reduction of arsenic-induced DNA damage in
lymphocytes after the treatment by selenium nanoparticles
[22]. Moreover, genoprotective effect of leaf extract of lem-
on plants used in green-synthesised colloidal selenium
nanoparticles was demonstrated after UV-induced DNA
damages in human lymphocytes, and could be used as po-
tential chemotherapeutic tool [140]. Also, apigenin com-
bined with poly-(lactide-co-glycolide) acid (PLGA) nano-
particles decreased the chromosomal aberrations in B[a]P-
andUVB-induced skin cancer invivo [19]. Interestingly, the
bioavailability of tea polyphenols (TPs) was improved by
chitosan and bovine serum albumin (BSA) nanoformulation
inmice.Animalswere fed by nanoparticles for 3 days before
irradiation exposure leading to enhancement of DNA stabil-
ity via the reduction of oxidative damage [141]. Similarly,
silver nanoparticles in combination with glycyrrhizic acid
protected Swiss albino mice against ionising radiation, by
decrease of DNA strand breaks formation and increase in
their repairs [142]. Moreover, theaflavin (TF) and
epigallocatechine-3-gallate (EGCG) in PLGA nanoparti-
cles exhibited a higher DNA protection compared with TF
a n d E G C G w i t h o u t n a n o c a r r i e r i n 7 , 1 2 -
dimethybenz[a]anthracene (DMBA)-induced DNA dam-
age in mouse skin [143]. Finally, PLGA-encapsulated
Phytolacca decandra showed the chemopreventive effect
with impact on DNA fragmentation, comet tail length, and
level of biomarkers such as NFκB, p53, PARP, ROS gener-
ation, CYP1A1, and caspase-3 in mouse model intoxicated
with B[a]P + sodium-arsenite [144].
Paradoxically, potential toxicity based on DNA oxidative
damage is associated with silver nanoparticles used in many
areas, including food, medical, and healthcare [145–147].
However, phytochemicals could counter this effect, as it was
described by the use of methanolic and aqueous extract of
Gentiana asclepiadea, which prevented toxicity of silver
nanoparticles treatment in human kidney HEK293 cells [148].
Clinical research evaluating genoprotective
activities of phytochemicals
Consumption of diet rich in substances of plant origin,
such as cruciferous vegetable, kiwifruits, fruit juice, or diet
of Mediterranean pattern, as well as beverages including
tea or coffee, is associated with potent cancer preventive
properties. The importance of genoprotective abilities of
plant substances was evaluated in clinical, mainly preven-
tive studies conducted on healthy or high-risk individuals
[18, 24, 26, 149–158].
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Antioxidant properties of phytochemicals
A mixed berry juice rich in anthocyanin/polyphenolics
decreased oxidative DNA damage and increased level of
reduced glutathione (GSH) and glutathione status in cells
of healthy participants while the observed decrease in ox-
idative DNA damage may be associated with direct anti-
oxidant effects such as ROS scavenging or chelation
[150]. Similarly, the decrease in cancer risk due to the
reduction of lymphocyte DNA damage and alterations in
the blood antioxidant status in healthy adults was associ-
ated with the consumption of watercress-based supple-
mentation. Interestingly, the beneficial effects of the sup-
plementation were more significant in smokers than in
non-smokers [149]. Furthermore, kiwifruit protected
healthy non-smokers against oxidative DNA damage, up-
regulated the level of antioxidant activity, and stimulated
DNA repair, which appears to be a result of an increased
stability of the OGG1 protein or availability of an un-
known co-factor and not by altered gene expression of
OGG1 or APE1. Interestingly, these changes were not
related to the number of kiwifruits consumed [18].
Three-month administration of the antioxidants ascorbic
acid (vitamin C) and D-α-tocopherol (vitamin E) in vol-
unteers with history of melanoma or no UV-induced skin
cancer increased antioxidant capacity of skin as demon-
strated by a significant decrease in thymine dimmers in-
duced by the UVB irradiation [158]. Additionally, green
tea polyphenols (GTP) decreased level of 8-OHdG in in-
dividuals with high risk of liver cancer [151].
Phytochemicals protecting against carcinogen-
induced DNA damage
Cooked Brassica carinata (no allyl isothiocyanate, AITC)
reduced DNA damage induced by aflatoxin B1 (AFB1) in
peripheral blood mononuclear cells of healthy participants
exposed to aflatoxin B1 with or without metabolic activa-
tion using human S9 mix when compared with baseline.
Raw B. carinata (AITS-containing) led to the reduction of
DNA damage by S9 activated AFB1 only. However, any
changes in plasma antioxidant capacity were not observed
in any group, which was possibly a result of no changes in
the content of total polyphenols due to cooking procedure.
Moreover, the bioavailability of phenolics may increase as
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all, antigenotoxic efficacy of B. carinata in healthy partic-
ipants is not primarily mediated by AITS due to the ab-
sence of AITC metabolites in plasma or urine of subjects
who consumed the cooked B. carinata leaves [152].
Further, the consumption of a hop flavonoid xanthohumol
(XAN) was associated with preventive properties against
DNA damage induced by dietary carcinogens in healthy
non-smokers. XAN substantially decreased B[a]P- and 2-
amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced
DNA damage while moderate protective effects were asso-
ciated with N-nitrosodimethylamine (NDMA) suggesting
an important protective efficacy of XAN against carcino-
gens detoxified by α-GST that represents major groups of
dietary carcinogens [154]. Moreover, coffee induced
GSTP, a member of GST isoenzymes, and protected lym-
phocytes of healthy subjects against DNA damage induced
by (+/-)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide (BPDE),
the DNA-reactive metabolite of B[a]P [155]. Similarly,
brussel sprouts protected peripheral human lymphocytes
of healthy participants against 2-amino-1-methyl-6-
phenylimidazo[4,5-b]pyridine (PhIP) possibly via the inhi-
bition of sulfotransferase 1A1, a key enzyme participating
in the PhIP activation. Moreover, the reduced oxidative
DNA damage due to the presence of compounds acting
as direct ROS scavengers was also attributed to the con-
sumption of sprouts [156].
High-phenol extra-virgin olive oil (EVOO) could be at
least partially associated with lower mortality or incidence of
cancer in regions characterised by Mediterranean diet.
Actually, the reduction of DNA damage was observed in
healthy postmenopausal women after the consumption of a
high-phenol EVOO [24]. Similar results were observed after
a consumption of carotenoid supplementation suggesting that
the combination of carotenoids (in doses easily achieved by
the diet) possesses protective abilities against DNA damage
[26]. Anticarcinogenic properties of cruciferous vegetables
are associated with improvement in cell protection against
DNA damage. The study evaluating protective effects of broc-
coli in healthy young male revealed significant decrease in
strand breaks in both smokers or nonsmokers and reduction
of oxidised purines in smokers [157].
Accordingly, an intake of natural substances, which ex-
ert potential genoprotective properties and subsequent che-
mopreventive abilities against several cancer types, should
represent a significant and important element of everyday
diet. Due to the presence of health-threatening compounds
in the human environment, we emphasize a significant pro-
tective effects of phytochemicals against damage leading
to carcinogenesis in both healthy and high-risk individuals
(Table 3).
The significant genoprotective abilities of plant natural
substances in preclinical, clinical, and nanotechnology ap-
proach described above are summarised in Fig. 4.
Protective and toxic interactions in the clinical setting
The secondary effects of oncological treatments, in terms of
chemo- and radiotherapy, and its management have been
widely addressed in multiple publications since their very be-
ginnings [159–161]. Different pharmaceutical options, in a
variety of presentations, are currently available for toxicity
management according to the affected region or tissue, and
their use has been included and recommended in various prac-
tice guidelines [162, 163]. However, not many studies have
addressed the potential benefits of natural compound
utilisation as a scientifically validated approach [164]. This
resembles an important topic to be evaluated, as depending
on factors such as the geographical provenance or cultural
background, the association between occidental and tradition-
al medicine could be a factor to consider in treatment decision-
making [165, 166]. It should be as well taken into account that
nearly 2 % of cancer deaths might be directly related to X-ray
exposure; therefore, major efforts to generate further knowl-
edge in this topic are warranted [167].
Several mechanisms to explain the chemo- or radio-
protective effect of plant-based management have been pos-
tulated. The high polyphenol content found in plants might be
one of the substances mediating the cytoprotective effect.
Through it, antioxidant enzymes may upregulate mRNA,
diminishing the oxidative response after radiation exposure;
additionally, DNA repair genes upregulation could contribute
ameliorating failures in double-strand repairing [168].
Additionally, generating reactive oxygen species and apopto-
tic pathways induction has been as well described as associ-
ated mechanisms [169].
Implicancies in radiation protection
On this molecular basis, different studies have been conducted
in order to prove its clinical impact. An investigation devel-
oped in the setting of cancer staging scans analysed the impact
of multi-agent antioxidant pills administrated before Tc99 iso-
tope application, containing ascorbate, n-acetylcystein
(NAC), lipoic acid, and beta carotene. DSBs were measured
both before and after imaging and compared between a con-
trol group and an interventional group. A significant DSB 60
% reduction was observed in the interventional group [170].
The expected profile of radiotherapy toxicity is quite
known according to the irradiated tissue, delivered dose,
volume of treatment, amongst other factors [171].
Radioprotectors, such as Amifostine, have proven to be
efficient in management, for example, of head and neck
cancer treatment-related toxicity; however, its availability
and implementation in clinical routine due to logistics or
elevated costs could impact its accessibility [172, 173]. On
the contrary, natural compounds or phytochemicals could
be found widely across the globe, although safety, dosing,
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and outcome data persist to be currently scarce.
Preliminary evidence of the effect of coffee (n = 75),
Matricaria recutita (n = 52), Aloe vera (n = 61), and
Calendula officinalis (n = 40) have shown a positive and
statistical significant impact in oral mucositis reduction in
prospective studies, although it is worth remarking that
these investigations might present selection bias
[174–176]. In the setting of breast cancer, the protective
effect of 6 g per os of curcumine was assessed throughout
the course of radiotherapy, randomised in a small cohort of
30 patients. The evaluated endpoint was moist desquama-
tion, which was positive in 28.6 % against 87.5 % for the
interventional and control groups, respectively [177].
Negative interactions between plants or phytochemicals
and radiotherapy have not been widely addressed and current
information regarding this topic remains sparse. In general
terms, only low-quality data showing no toxic crossed-
interactions has been to date reported [178, 179]. However,
caution must be taken for smoker patients during radiothera-
py. The administration of antioxidants to this particular sub-
groups of patients has shown in a randomised trial, that it
could carry an increased recurrence and mortality rate risk
(HR 2.42 and 2.26, respectively) compared with the control
non-interventional group, probably due to an elevation of seric
carboxyhemoglobine, thus decreasing the oxygen-dependant
radiotherapy effect [180, 181].
In addition, further research is being currently carried to-
wards clarifying the radiosensitizer role of phytochemicals
such as flavonoids, in order to enhance radiotherapy´s
therapeutical ratio [182].
Implicancies in chemotherapy
In regard to chemotherapy or combined radiochemotherapy,
toxicity rates still represent a recurrent issue to be solved,
causing treatment interruptions in detriment of the expected
oncological outcomes. A Cochrane systematic review
analysed the results of 4 different studies who compared che-
motherapy alone against chemotherapy plus traditional
Chinese herbal medicine as cytoprotector. With 342 included
subjects in total, and although a low-quality level was ob-
served amongst the trials and no robust evidence could be
obtained, the collected data points towards an improvement
in immunocompetent cell stimulation and side effect decrease.
Besides this, no toxic effect was associated to plant usage
[183]. This hypothesis-generating conclusion should be con-
sidered baseline for further research with adequate
methodology.
The willingness of natural medicine utilisation in certain
regions ought to be of the oncology practitioners’ knowledge
[184, 185]. Due to the wide spectrum and availability of nat-
ural products and lack of knowledge dissemination in terms of
Fig. 4 Overview of plant natural substances which are associated with
genoprotective abilities in preventive and therapy studies. SO, Salvia
officinalis; RWPSs, powdered red wine pomace seasonings; LEO,
lemongrass essential oil; CHI, Chrysobalanus icaco; SEE, Sechium
edule extract; HIHE, Hemidesmus indicus hydro-alcoholic extract; FCE,
Ficus carica leaf extract; BE, Brachystegia eurycoma; AC and AXC,
Allium cepa L. and Allium × cornutum; BM, Butea monosperma; WA,
withaferin A; ICZ, indolo[3,2-b]-carbazole; EDME, Euphorbia
dracunculoidesmethanol extract; CSME, Crataegus songaricamethanol
extract; TRCEO/γ-T/p-C, Thymus revolutus Célak essential oil/γ-
terpinene/p-cymene; FLAX, flaxseed; MEPPS/PONG/LanB, methanol
extract of Pongamia pinnata seeds/pongapin/lanceolatin B; YB, young
barley; CB, clove buds; THY, thyme; FPP, fruit peel polyphenols; CIN,
cinnamon; vit. C and vit. E, vitamin C (ascorbic acid) and vitamin E (D-
α-tocopherol); GTP, green tea polyphenols; A/PFJ, anthocynin/
polyphenolic-rich fruit juice; EK, Ethiopian kale (Brassica carinata);
EVOO, extra-virgin olive oil; XAN, xanthohumol; SNPs, silver nanopar-
ticles; GA, glycyrrhizic acid; TF, theaflavin; EGCG, epigallocatechine-3-
gallate; PLGA, poly (lactide-co-glycolide) acid; TP, tea polyphenols;
BSA, bovine serum albumin; APIG, apigenin; SeNPs, selenium
nanoparticles
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potential adverse events, caution should be taken while pre-
scribing or delivering treatment. This is supported by an anal-
ysis comparing drug- (DDI) and herb-drug (HDI) interactions
in cancer care. In these 149 patient cohorts, 36 clinically rel-
evant DDI in 26 patients (17.4 %) and 122 HDI in 84 patients
(56.4 %) were detected [186]. The importance of acknowledg-
ing the patient’s treatment desires lies in predicting and
preventing potential harmful interactions combined with the
indicated treatment. Besides, an important number of patients
(~ 58 %) tend to hide this information from their treating phy-
sicians, which may also increase the risk of developing ad-
verse events [187].
Different mechanisms have been described for explaining
potential undesired interactions. The interference in P450 iso-
zyme metabolism or drug transporter P-glycoprotein function
due to consumption of garlic (Allium sativum), Ginko biloba,
Echinacea purpurea, ginseng (Panax ginseng), amongst
others, has been already mentioned in the literature as poten-
tial triggers for hepatic toxicity and reduced anticancer therapy
effects [164, 188].
In contrast and reported by two randomised studies, higher
seric concentrations of selenium and vitamin E have shown to
improve hemathologic toxicity and neuropathy, respectively,
in the setting of cisplating administration [189, 190].
Therapeutic and preventive ratio enhancement
Evidence from different publications, including one systemat-
ic review of 49 human studies, have highlighted the non-
interfering profile of natural compounds with radiotherapy,
such as beta-carotene, vitamins A, B, E, selenium, amongst
others. Moreover, a lower rate of secondary effects enhanced
tumouricidal action, and even potentially survival benefit
[178, 182, 191].
Although widely studied in pre-clinical trials, no strong
evidence in human subjects has been collected to date, in to
classify phytochemicals usage and dosing in a defined clinical
scenario. The example of breast cancer patients has shown,
mostly in vitro, different action levels regarding proliferation,
apoptosis, and metastasis, for specific compounds. For in-
stance, resveratrol has shown reducing negative features by
acting on estrogen receptors (ER), EFGR/PI3K, and ERK1/2
pathways. Additionally, the activity of other phytochemicals,
like lignans or curcumin, inhibiting the HER-2 pathway,
might be as well of benefit for specific case scenarios [192].
Clinical evidence extracted from other compound usage expe-
rience (isoflavones) opens a new path for further research. As
it has been reported, a seemly lower rate of breast cancer has
been related to its consumption in someAsian countries [193].
In addition, a prospective Spanish trial demonstrated the pro-
tective effect of the Mediterranean diet against breast cancer
development [194, 195]. Caution while interpreting these
publications is suggested, as theymight incur in selection bias.
New approaches will be developed in the upcoming years
with further vegetal species under the scope. Initial reports of
antitumoural activity of Banisteriopsis caapi, for example,
through various hypotetical molecular pathways, such as
N,N-dimethyltryptamine in the intracellular sigma-1 recep-
tors, and the activity of harmine, tetrahydroharmine, and
harmaline, are generating great expectations to delucidate
their potential contribution in cancer care [196]. Other studies
currently undergoing in various institutions, to demonstrate
the value of different phytochemicals for specific sites, are
eagerly awaited to increase the oncologists’ therapeutical
arsenal.
Chemoprevention exemplified for individual
stages of cancer’s risk, development,
and progression
As it was detailed above, several plant natural substances
demonstrate genoprotective effects by complex antioxi-
dant and detoxification activities, neutralisation of carcin-
ogens, and DNA repair promotion. On the other hand,
cytotoxic and genotoxic effects of plants and extracts have
been demonstrated towards quickly proliferating tumour
cells discriminating them against physiologic tissue [197,
198]. Below paragraphs illustrate clinically relevant effects
applicable to
– general cancer prevention
– pre-cancerous lesions—individualised cancer prevention
– selective cytotoxic effects against malignancies
– circulating tumour cells and metastatic disease—
mitigating strategies
– phytochemical supplement in optimal palliative care
setting
as exemplified specifically for colon carcinomas.
General colon cancer prevention in the population
Multi-factorial stress conditions leading to the excessive pro-
duction of ROS are well-acknowledged to cause cancer pre-
disposition as reported for hepatocellular carcinoma, glioma,
malignancies of the blood, breast, colorectum, esophagus, kid-
ney, lung, mouth, ovary, pancreas, prostate, and stomach
[199]. To this end, the risk of developing malignancies is
associated with the dose as well as timing of the exposure
[200]. Consequently, individualised predictive approach is es-
sential to make the primary prevention targeted and cost-
effective [201, 202].
One of the most ubiquitous stress factors is an imbal-
anced and/or unhealthy diet increasing the general predis-
position to colon cancer [203]. Specifically, so-called
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Western Diet Pattern is characterised by high intake of
processed meat, red meat, or high-fat dairy products
[204] being associated with an increased risk of colon can-
cer [167, 168]. In contrast, the Mediterranean diet pattern
based on fruits and vegetables rich in various phytochem-
icals shows chemopreventive anticancer effects mediated
via complex antioxidant, detoxification, and free radical
scavenging activities [205, 206]. Unfortunately, people at
high risk, due to genetic (inborn family) predisposition to
colon cancer are not sufficiently responsing to a dietary
prevention [207]. Consequently, supplementary protective
measures are currently under extensive consideration such
as improved microbiome setup as well as probiotics and
nanoparticles with prebiotic properties supportive for im-
mune system and applied depending on the individual pre-
disposition and personalised patient profile [208, 209].
Pre-cancerous lesions and malignant cell
transformation
Pre-cancerous colon lesions, such as polyps, ulcers, ero-
sions, vascular lesions, mass, and nodules, are considered
prestages of the colon cancer development [210]. Early
diagnosis of multiple adenoma, a precursor to colorectal
cancer, followed by application of plant natural substances
may be highly protective reducing the overall risk of can-
cer development [174]. For example, Lynch syndrome pa-
tients, who are predisposed to various cancers including
colorectal carcinomas and suffering from insufficient
DNA repair capacity, demonstrate reduced inflammation
and overall cancer risks by intake of nutritional Nrf2 acti-
vators such as phytochemicals (sulforaphane, curcumin,
quercetin, resveratrol, and EGCG) [211]. Further, progres-
sion of neoplastic lesions into colon cancer is suppressed
by Salvia officinalis tea via its chemopreventive effects
[118]. To this end, the transformation of neoplastic lesions
into malignant cells and anticancer effects by phytochem-
icals might be highly selective by killing rapidly prolifer-
ating cells [212]. Specifically, Premna odorata leaves,
P. odorata bark hexane fractions and Artocarpus camansi
leaves were found to be highly cytotoxic against HCT116
human colon cancer cell line, with P. odorata bark hexane
extract demonstrating high selectivity/cytotoxic index
[213]. Similar effects have been demonstrated also for sev-
eral cancer types: triterpenoids, oleanolic acid 3-acetate,
and betulinic acid, isolated from dichloromethane extracts
of Clerodendrum indicum and Clerodendrum villosum, re-
vealed moderate to strong cytotoxicity to colorectal adeno-
carcinoma (SW620), bronchogenic carcinoma (ChaGo-K-
1), hepatocellular carcinoma (HepG2), gastric carcinoma
(KATO-III), and ductal carcinoma (BT-474) cancer cell
lines [214].
Cytotoxic effects to suppress circulating tumour cells
and metastatic disease
Some plants via their content compounds exhibit selective
cytotoxic effects against circulating tumour cells and metasta-
tic potential. Specifically, apigenin, which can be detected in
many vegetables and herbal spices, is capable to inhibit
epithelial-mesenchymal transition (EMT) of human colon
cancer cells that plays an essential role in the cancer metastasis
progression [215]. Similarly, natural polyphenol calebin A, a
component of turmeric, evidently suppresses proliferation, in-
vasion, and metastasis spread by human colorectal cancer
cells [216]. Considering corresponding molecular mecha-
nisms, phytochemicals are capable to perturb signalling path-
ways associated with the cancer progression. Further clinical
studies are needed to understand in more detail how patients
can be best stratified for anticancer and anti-metastatic medi-
cation by well selected plants and phytochemicals.
Plant and phytochemical supplement in optimal
palliative care setting
The concept of palliative care provided to cancer patients is
currently evolving from just end of life care and relieve suf-
fering to include all aspects of cancer survivorship. The new
challenging concept needs to thoroughly consider diet and
nutrition which positively impact individual outcomes by af-
fecting cancer recurrence and progression. To this end, clear
evidence is provided that herbs and their constituent phyto-
chemicals may be biologic response modifiers that could in-
crease cancer control within palliative care [217]. Moreover,
herb and dietary supplements are the most popular comple-
mentary and alternative medicine modality used by cancer
patients. How much they are supportive and whether they
may interfere with the efficacy and safety of conventional
medicines remains to be further investigated [218].
Concluding remarks, expert
recommendations and outlook
Natural substances represent an attractive strategy for cancer
primary and secondary prevention [219–221]. Preclinical can-
cer research demonstrated potent genoprotective properties of
natural plant substances in non-cancer models [103, 106,
124–126, 222]. Regarding clinical research, the uses of germ-
line, familiar, or high-risk cohorts are associated with more
power over a shorter time frame of the clinical trials when
compared with subjects with average risk [223]. Identification
of high-risk individuals who would benefit from targeted pre-
ventive strategies described above is an essential measure
which may significantly reduce cancer incidence in the popu-
lation. Multi-level diagnostics, including phenotyping and
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genotyping, is considered an optimal tool for prediction and
targeted prevention [224, 225]. Further, multiomics plays a
key role in cancer predictive and early diagnostics [226].
By evidence, administration of plant natural substances
and/or diet supplements slows down or even inhibits car-
cinogenesis in healthy and high-risk individuals. Plant
natural substances and phytochemicals decrease oxidative
damage to biologically important molecules, increase an-
tioxidant status and scavenging capacity against excessive
ROS production; thereby, cells are better protected against
c a r c i nogen - i nduced DNA damage and bo th—
detoxification and DNA repair pathways—are stimulated
[18, 24, 26, 149–158]. However, clinically relevant rec-
ommendations in this regards are still underrepresented.
Obviously clinical trials focused on individualised patient
profiles and consequent patient stratification would be
useful to bring the preclinical discoveries in the field to
the daily clinical practice benefiting the patients and
healthcare as the whole. To this end, since a large part
of cancers is considered preventable, particularly primary
chemoprevention may offer plausible solutions to address
the global problem of increasing cancer incidence [227,
228]. In general, innovative approaches by preventive
medicine provide new opportunities for clinical oncology
[193]. 3PM strategies are considered being particularly
important to advance the overall cancer management mak-
ing the services cost-effective [194]. As detailed above,
chemopreventive strategies play an important role in the
context of 3P medicine [229]. However, further research
for determining active compounds and dosing selection is
urgently warranted to effectively promote their clinical
implementation in terms of primary and secondary che-
moprevention as well as cancer management as a whole
[230–232].
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